# Adagio Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adagio-medical

- Industry: Medical Devices & Equipment
- Headquarters: Laguna Hills, US
- Website: www.adagiomedical.com
- Total disclosed funding: $43M
- Latest round: Series E (Nov 12, 2020)
- Investors on record: 5

## About

Adagio Medical, Inc., based in the US, specializes in developing advanced medical technologies for cardiovascular and endovascular interventions, delivering innovative solutions aimed at improving patient outcomes in minimally invasive procedures.Adagio Medical, Inc. is a company focused on advanced medical technologies for cardiovascular interventions, founded in 2011 and headquartered in Laguna Hills, California, US. The company has engaged in 7 total deals with its most recent deal occurring in October 2022. In this round, Adagio Medical raised USD 9.5 mn in Venture Debt led by Perceptive Advisors, bringing the total amount raised to USD 42.5 mn. Adagio Medical Inc. specializes in advanced medical technology, focusing on innovative solutions for cardiovascular and endovascular interventions. The company's core product offerings include a range of medical devices designed to enhance patient outcomes in minimally invasive procedures. These products address critical challenges faced by healthcare professionals, such as improving procedural efficiency and reducing recovery times for patients. Adagio Medical's technologies are utilized by hospitals and specialized clinics, serving a diverse client base including cardiologists, vascular surgeons, and interventional radiologists. The company markets its products primarily within the United States and select European countries, where the demand for advanced medical solutions is growing.The revenue structure of Adagio Medical Inc. is primarily based on direct sales of its medical devices to hospitals and healthcare facilities. Transactions typically occur through a business-to-business model, whereby healthcare providers purchase the company's flagship products, supported by comprehensive training and customer service. The firm also engages in partnerships with key distributors to expand its reach within the healthcare market, allowing for a streamlined distribution process. Pricing plans reflect the value of the technology provided, focusing on competitive pricing strategies that cater to both large healthcare systems and smaller clinics. Revenue generation is further supported by ongoing support services, ensuring that clients derive maximum benefit from the products over their lifecycle.In October 2022, Adagio Medical raised USD 9.5 mn in convertible notes from leading investor Perceptive Advisors. The recent funding is expected to support the development of new products aimed at enhancing their current offerings. The company plans to expand into new markets, targeting specific regions in Europe by the end of 2023. These initiatives are aligned with Adagio's strategy to grow its market presence and enhance its product portfolio.

## Funding rounds

- Series E, Nov 12, 2020, $43M — ArrowMark Partners, Fjord Ventures, RA Capital Management, Perceptive Advisors, JMR Capital Partners

## Investors

- ArrowMark Partners — Series E
- Fjord Ventures (https://capitalatlas.ai/funds/fjord-ventures) — Series E
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series E
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series E
- JMR Capital Partners — Series E